APA aipamena

Bhattacharyya, S., & Katare, S. (2020). SUN-LB112 Efficacy & Safety After Switchover to Remogliflozin in Indian T2DM Patients - a Real World Study. J Endocr Soc.

Chicago Style aipamena

Bhattacharyya, Supratik, and Sagar Katare. "SUN-LB112 Efficacy & Safety After Switchover to Remogliflozin in Indian T2DM Patients - a Real World Study." J Endocr Soc 2020.

MLA aipamena

Bhattacharyya, Supratik, and Sagar Katare. "SUN-LB112 Efficacy & Safety After Switchover to Remogliflozin in Indian T2DM Patients - a Real World Study." J Endocr Soc 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.